1622075-65-3
1622075-65-3
Chemical Structure
Moxetumomab
- CAS No.: 1622075-65-3
- Formula:N/A
- Molecular Weight:(146.14 kDa)
IUPAC Name: methyl (S)-2-amino-3-(4-(((fluoro-18F)sulfonyl)oxy)phenyl)propanoate
SMILES: [Moxetumomab]
Biological Activity: Moxetumomab is a CD22-targeting monoclonal antibody that forms the component of Moxetumomab Pasudotox, a recombinant CD22-targeting immunotoxin. Moxetumomab binds to CD22 on malignant B cells and delivers the PE38 toxin domain to tumor cells. Moxetumomab can be used in research on relapsed or refractory hairy cell leukemia[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Moxetumomab | 99.77% | Moxetumomab is a CD22-targeting monoclonal antibody that forms the component of Moxetumomab Pasudotox, a recombinant CD22-targeting immunotoxin. Moxetumomab binds to CD22 on malignant B cells and delivers the PE38 toxin domain to tumor cells. Moxetumomab can be used in research on relapsed or refractory hairy cell leukemia. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
